Microcephalin (MCPH1/BRIT1) is a potential tumour suppressor that localizes to the centrosome, forms ionizing radiation-induced nuclear foci (IRIF) 
Introduction
Current models for cancer invoke loss of genome integrity as a major step towards transformation. To protect this integrity, cells possess a complex and coordinated network of responses to DNA damage, which can be generated during normal metabolism or be induced by exogenous stresses (Jackson and Bartek, 2009) . A fully functional DNA damage response network thus represents a significant early barrier to tumourigenesis (Bartkova et al., 2005; Gorgoulis et al., 2005) .
Aneuploidy and chromosomal instability are closely correlated with excess centrosomes, the major microtubule-organizing centre in animal cells. Aberrant centrosomal numbers are frequently observed in tumours and multipolar mitotic figures are seen in cells with multiple centrosomes (D 'Assoro et al., 2002; Nigg, 2002) . It has long been suggested that multipolar mitoses could cause abnormal chromosomal segregation and aneuploidy, thus contributing to cancer development (Brinkley, 2001) . A recent paper indicated a mechanism whereby chromosome mis-segregation results from the establishment of merotelic kinetochore attachments to both spindle poles during a transient multipolar phase (Ganem et al., 2009) . In both these models, centrosome number is an important determinant of genome stability.
Microcephalin (MCPH1/BRIT1) is a component of the DNA damage response network that also localizes to centrosomes. MCPH1 was originally described as a transcriptional repressor of the human telomerase reverse transcriptase, BRIT1, for BRCT-repeat inhibitor of hTERT expression (Lin and Elledge, 2003) . Its designation as MCPH1 stems from the observation that the MCPH1 gene is mutated in the autosomal recessive disease, primary microcephaly (OMIM 251200; Jackson et al., 2002) . MCPH1 mutations also occur in premature chromosome condensation syndrome (OMIM 606858) , in which mitotic chromosomes condense early in an otherwise unperturbed cell cycle (Trimborn et al., 2004) .
MCPH1 has several roles in maintaining genome stability and suppressing tumourigenesis. MCPH1 was found in ionizing radiation-induced nuclear foci (IRIF) with MDC1/NFBD1 and phosphorylated H2AX (g-H2AX) (Xu et al., 2004; Lin et al., 2005) . Depletion of MCPH1 in human cells blocked the formation of IRIF by NBS1, 53BP1, phosphorylated ATM and MDC1, but not g-H2AX (Rai et al., 2006) , placing MCPH1 downstream of H2AX phosphorylation in the DNA damage response. DNA damage-induced chromatin association of several DNA damage response proteins was also blocked and a high level of chromosome aberrations were observed after knock down of MCPH1 (Rai et al., 2006) . RNA interference studies in human cells have shown MCPH1 to mediate the DNA damageresponsive S and G2-M phase checkpoints, controlling the levels of BRCA1 and the checkpoint kinase, CHK1 (Xu et al., 2004; Lin et al., 2005) , subcellular localization of which is also controlled by MCPH1 (Tibelius et al., 2009) . MCPH1 knockdown cells and Mcph1 À/À mice and cells also show increased radiosensitivity (Peng et al., 2009; Liang et al., 2010) . Defective homologous recombination and a chromosome condensation defect have been observed in Mcph1 À/À mouse cells (Wood et al., 2008; Liang et al., 2010; Trimborn et al., 2010) and a role for MCPH1 in controlling homologous recombination activities has been described in human cells (Peng et al., 2009; Wu et al., 2009) . A recent paper has shown that MCPH1 regulates the adenosine triphosphate-dependent chromatin remodelling of SWI-SNF complex, altering the chromatin structure in response to DNA damage to facilitate DNA repair (Peng et al., 2009) . These data show that MCPH1 contributes both to checkpoint responses and to DNA repair.
We and others have shown that MCPH1 localizes to the centrosome, the key microtubule-organizing centre of animal cells (Jeffers et al., 2008; Rai et al., 2008) . Furthermore, centrosomal anomalies have been described in lymphoblastoid cells derived from microcephaly patients (Alderton et al., 2006) . Mitotic abnormalities described in MCPH1-deficient cells have suggested that the normal functioning of the mitotic spindle is partially controlled by MCPH1 (Rai et al., 2008) . Interestingly, MCPH1 and the pericentriolar scaffold protein, pericentrin, are both required for normal centrosomal localization of CHK1 and regulation of mitotic entry through Cdk1 activation (Tibelius et al., 2009) . Consistent with its important roles in genome stability and mitosis, MCPH1 expression is significantly reduced in breast and ovarian tumours compared with normal samples, with accelerated metastasis observed in patients with low MCPH1 levels, suggesting that MCPH1 is a tumour suppressor (Rai et al., 2006) . Together, these observations indicate a multifaceted role for MCPH1 in cell-cycle control and genome maintenance. Here, we use reverse genetics in the hyper-recombinogenic DT40 cell line to explore the roles of Mcph1 in controlling the centrosome and associated activities.
Results
To examine how Mcph1 controls the cell cycle and centrosomal responses to DNA damage, we targeted Mcph1 in the hyper-recombinogenic chicken DT40 cell line. Targeting vectors were prepared using genomic PCR ( Figure 1a ) and transfectants were analysed by Southern blot for targeted integration of the gene disruption construct (Figure 1b) . As shown in Figure 1c , targeting of the Mcph1 locus abrogated the expression of the gene.
Mcph1
À/À cells proliferated at a similar rate to wild-type cells (Figure 1d) , showing that this gene is not required for cell viability or cell cycle progression.
Next, we tested whether Mcph1 deficiency impacted on the ability of cells to respond to DNA damage. We examined the ability of Mcph1 À/À cells to survive genotoxic stress using clonogenic survival assay ( Figure 2a) . We saw only a moderate difference in survival between wild-type and Mcph1
À/À cells in two independent clones examined after ionizing radiation (IR) treatment, showing that Mcph1 is not a major determinant of cell survival after IR treatment. To assess the functioning of G2-to-M checkpoints, we induced DNA damage in control and Mcph1-deficient cells that we trapped in M phase using colcemid. Untreated cells showed an increase in mitotic index over time, as determined by 

À/À cells showed an arrest by 8 h and began returning to their cell cycle by 12-24 h, although, a return to the normal cell cycle was not complete by 48 h, suggesting a deficiency in checkpoint recovery (Figure 2c; Supplemental Figure 1 ). Taken together, these data indicate that Mcph1-deficient cells have an intact G2-to-M checkpoint and a robust ability to respond to genotoxic insult, despite showing an attenuated resolution of damage-induced cell cycle arrest.
Our next question was whether Mcph1 was required for centrosome integrity. We examined centrosomes in Mcph1 À/À DT40 cells using immunofluorescence microscopy. As shown in Figure 3a , the centrosome markers g-tubulin, centrin, aurora-A and Cep76 (Tsang et al., 2009 ) all localized to normal and IR-amplified centrosomes in both wild-type and Mcph1-deficient cells. We then used electron microscope to further dissect the ultrastructure of the centrosomes. In both wild-type and (a) Clonogenic survival assays of clones treated with IR were performed as described (Takata et al., 1998) 
. Plating efficiency of Mcph1
À/À cells was B50% that of wildtype. (b) G2-to-M checkpoint analysis. Cells were stained with polyclonal antibodies to phospho-histone H3 (06-570; Upstate/Millipore, Carrigtwohill, Ireland) and mitotic indices were assessed by flow cytometry. Cells were blocked in 0.1 mg/ml colcemid from the onset of the experiment, when they were treated with 2 Gy IR, as indicated. (c) Flow cytometry analysis of cells of the indicated genotype performed at the indicated times after 5 Gy g-irradiation from a 137 Cs source. Cells were fixed in 70% ethanol then stained with propidium iodide (40 mg/ml) in phosphatebuffered saline containing RNase A (100 mg/ml) and sorted on a FACScalibur (BD Biosciences, Erembodegem, Belgium).
Mcph1 restricts DNA damage-induced centrosome amplification JAL Brown et al
Centrosome overamplification after IR is a frequent consequence of an aberrant response to DNA damage (Dodson et al., 2004; Loffler et al., 2006) . We speculated that, despite the robust ability of our Mcph1 À/À DT40 cells to survive irradiation, the DNA damage response might be defective in these cells, as suggested by the delayed recovery from DNA damage seen in Figure 2c . Mcph1 restricts DNA damage-induced centrosome amplification JAL Brown et al (Rai et al., 2006; Jeffers et al., 2008) . Interestingly, we also observed Rad51 IRIF (Figure 4a ), which were impeded by RNA interference knockdown of MCPH1 in human cells (Wu et al., 2009) . We quantitated these IRIF and found that, although Mcph1-deficient cells formed foci with kinetics similar to wild-type cells, the resolution of g-H2AX foci, and to a lesser extent of Rad51 foci, was slower than that seen in wild-type cells (Figures 4b and c) . These observations are consistent with an extended cell cycle checkpoint after DNA damage. With our previous results having implicated Chk1 as a key signal in allowing centrosome amplification after IR (Bourke et al., 2007) , we tested how Mcph1 deficiency impacted on Chk1 signalling. As shown in Figure 4d , IR-induced Chk1 phosphorylation in wildtype cells was strongest at 0.5-1 h after irradiation and was absent by 4 h post-IR. In Mcph1 À/À cells, however, this phosphorylation was still detectable up to 6 h after irradiation, providing further evidence for a delay in checkpoint resolution. Importantly, expression of Myc-
Mcph1 in Mcph1
À/À cells relieved this delay and caused phospho-Chk1 levels to return to normal with wild-type kinetics (Figure 4e ). Consistent with the sustained checkpoint signalling leading to Cdk2 Thr-160 phosphorylation and activation (Bourke et al., 2010) , we found that Mcph1 deficient cells showed a strong induction of activating Cdk2 phosphorylation earlier after IR treatment than that was seen in wild-type cells (Figure 4f ). These findings suggest that Mcph1 restrains centrosome amplification after damage through the timely removal of the Chk1 signal that arises during the DNA damage response and drives centrosome duplication by activating Cdk2.
Discussion
RNA interference experiments in human cells and gene disruption experiments in murine cells have not shown any lethality resulting from MCPH1 depletion, consistent with the viability of the Mcph1 À/À DT40 cells (Xu et al., 2004; Lin et al., 2005; Yang et al., 2008; Tibelius et al., 2009; Liang et al., 2010; Trimborn et al., 2010) . No impact on proliferation or on mitotic index was seen in Mcph1 À/À DT40 cells. A mitotic delay has been described after MCPH1 knockdown in U2OS cells (Rai et al., 2008; Tibelius et al., 2009) , but other groups also using U2OS cells reported no mitotic defects upon depletion of MCPH1 (Xu et al., 2004; Lin et al., 2005) . MCPH1 RNA interference in lymphoblastoid cells had no effect on the mitotic index (Alderton et al., 2006) . Chromosome condensation defects have been observed in two murine models of Mcph1 deficiency, but detailed mitotic analysis has not yet been reported (Wood et al., 2008; Liang et al., 2010; Trimborn et al., 2010) . Analysis of Drosophila Mcph1 mutants revealed syncytial embryonic lethality that is associated with mitotic arrest, but no such impact was seen in adult flies (Brunk et al., 2007; Rickmyre et al., 2007) . Taken together, these data suggest that Mcph1 is not required for normal cell cycle progression in somatic cells. siRNA knockdown of MCPH1 in human U2OS cells impairs G2-to-M checkpoint induction and leads to radiosensitivity (Xu et al., 2004; Lin et al., 2005) . Lymphoblasts with truncating MCPH1 mutations also show aberrant G2-to-M checkpoint arrest (Alderton et al., 2006) . Mice and embryonic fibroblasts from a gene targeting experiment, in which the murine Mcph1 locus was disrupted at exon 2 were radiosensitive and showed elevated levels of IR-induced chromosome abnormalities (Liang et al., 2010) . These observations sit well with the activation and IRIF formation of Mcph1 in the DNA damage response (Xu et al., 2004; Lin et al., 2005; Wood et al., 2007; Jeffers et al., 2008) . The absence of a pronounced impact of Mcph1 deficiency on G2-to-M checkpoint activation and radioresistance in DT40 cells was unexpected, although our IRIF and checkpoint analyses revealed a delay in the resolution of DNA damage in Mcph1 mutant cells that might have a more significant impact during development. Interestingly, Mcph1 mutation in Drosophila did not increase larval radiosensitivity, and eye-antennal imaginal disc cells from Mcph1 mutants showed intact G2-to-M arrest after IR treatment (Rickmyre et al., 2007) . Therefore, species-or tissuespecific redundancies within the DNA damage response may be one explanation for the varying effects of Mcph1 loss in different systems. Furthermore, the loss of Mcph1 activities in the DNA damage response may be balanced by the reduction of Mcph1-directed pro-apoptotic activities, such as those mediated by E2F1 (Yang et al., 2008) . Immunofluorescence microscopic analysis of the centrosome was performed as described (Dodson et al., 2004; Bourke et al., 2007) . Primary antibodies used were against aurora-A (35C1; Abcam, Cambridge, UK), centrin (#628802; Biolegend Vithoorn, The Netherlands), Cep76, g-tubulin (monoclonal GTU88 and polyclonal T3559; Sigma, Dublin, Ireland). Merged micrograph images show g-tubulin in red, DNA in blue and the second marker in green. Scale bar, 10 mm. (b) Cells were processed for transmission electron microscopy using an established protocol (Liptrot and Gull, 1992 ) that consisted of: primary fixation in a mixture of 2% glutaraldehyde and 2% paraformaldehyde in 0.1 M cacodylate buffer followed by osmication in 2% osmium tetroxide, dehydration and embedding in Agar Low Viscosity Resin (Agar Scientific, Essex, UK). Sections were cut on a Reichert-Jung Ultracut E microtome (Leica, Wetzlar, Germany), stained with uranyl acetate and lead citrate, then viewed on a H-7000 Electron Microscope (Hitachi, Maidenhead, UK). Scale bar, 100 nm. and Rad51 IRIF in wild-type and Mcph1 À/À cells before and 4 h after 5 Gy g-irradiation. DT40 cells were fixed and stained with monoclonal anti-g-H2AX (red; JBW301, Millipore) and rabbit polyclonal anti-Rad51 (green; PC130, Calbiochem/Merck, Darmstadt, Germany) antibodies as previously described (Bourke et al., 2007) . DNA was stained with DAPI (blue). Scale bar, 10 mm. À/À clones used in Figure 3e . (f) Immunoblot analysis of Cdk2 phosphorylation was carried out before or at the indicated times after 5 Gy g-irradiation using rabbit anti-phospho Cdk2 T160 (2561; Cell Signaling), with polyclonal goat anti-Cdk2 (sc163 g ; Santa Cruz, Heidelberg, Germany) and actin as loading controls.
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